Medicine
Ryzneuta 20 mg/1 mL injection
Ryzneuta 20 mg/1 mL injection is a prescription medicine containing Efbemalenograstim alfa for subcutaneous use, marketed by Acrotech Biopharma, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians. It ships in a temperature-controlled cold chain.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Cold chain
Store refrigerated at 2°C to 8°C (36°F to 46°F) in the carton to protect from…
Key facts
- Active ingredient (INN)
- Efbemalenograstim alfa
- Brand
- Ryzneuta
- Strength
- 20 mg/1 mL
- Dosage form
- Injection
- Route
- Subcutaneous
- Packs
- 1 syringe of 1 mL
- Marketing authorisation holder
- Acrotech Biopharma
- Manufacturer
- Acrotech Biopharma
- Origin register
- US FDA, United States
- Storage
- Store refrigerated at 2°C to 8°C (36°F to 46°F) in the carton to protect from light. Do not freeze. Discard syringes stored at room temperature for more than 48 hours. Do not shake.
- Cold chain
- Yes, shipped temperature controlled
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- L03AA18 Efbemalenograstim alfa
- HS code (indicative)
- 3002.15Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 23 November 2023
- Identifiers
- RxCUI 2670662, 2670669DailyMed set ID 290ed754-758c-9cae-e063-6294a90ae68bNDC 72893-016Application BLA761134
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 1 syringe in 1 carton / 1 mL in 1 syringe | 72893-016-02 | Acrotech Biopharma | 23 November 2023 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Clinical summary
Efbemalenograstim alfa is a leukocyte growth factor indicated to decrease the incidence of infection, as manifested by febrile neutropenia, among other approved uses. MedsAcross supplies Efbemalenograstim alfa for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about Efbemalenograstim alfaFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- RYZNEUTA prescribing information (Acrotech Biopharma) · U.S. National Library of Medicine, DailyMed
- Ryzneuta: European public assessment report (EPAR) · European Medicines Agency
Need Ryzneuta 20 mg/1 mL injection for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.